Literature DB >> 2008835

Diagnostic value of ventricular stimulation in patients with idiopathic dilated cardiomyopathy.

B Brembilla-Perrot1, J Donetti, A T de la Chaise, N Sadoul, E Aliot, Y Juillière.   

Abstract

To assess the response to programmed ventricular stimulation and the clinical outcome, we performed a prospective study in 103 patients with idiopathic dilated cardiomyopathy. The protocol used up to three extrastimuli delivered at two right ventricular sites during sinus rhythm and ventricular pacing at 100 and 150 beats/min and was repeated during infusion of 1 to 4 micrograms/min of isoproterenol. Sustained monomorphic ventricular tachycardia (VT) was induced in 8 of 11 patients with spontaneous sustained VT, in none of 35 patients without significant ventricular arrhythmias during Holter monitoring, and in 9 of 56 patients with salvos of ventricular premature beats. Isoproterenol infusion facilitated the induction of two episodes of sustained VT in patients with spontaneous sustained VT; however, in all but one of the remaining patients, induction of ventricular tachyarrhythmias was not impaired. During the follow-up period there were eight sudden deaths among patients who initially had syncope, inducible sustained VT, or both and three episodes of sustained VT in patients who initially had nonsustained VT but inducible sustained VT. Isoproterenol infusion can be used to safely facilitate induction of ventricular tachyarrhythmias in patients with dilated cardiomyopathy. The induction of sustained VT was associated with a poor prognosis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2008835     DOI: 10.1016/0002-8703(91)90672-5

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  11 in total

Review 1.  Patients with ventricular arrhythmias: who should be referred to an electrophysiologist?

Authors:  John M Morgan
Journal:  Heart       Date:  2002-11       Impact factor: 5.994

Review 2.  Diagnosis and management of ventricular tachycardia.

Authors:  M Dancy
Journal:  Postgrad Med J       Date:  1992-06       Impact factor: 2.401

Review 3.  Ventricular arrhythmias in congestive heart failure: clinical significance and management.

Authors:  G R Khoshnevis; A Massumi
Journal:  Tex Heart Inst J       Date:  1999

Review 4.  Identification and management of the high risk patient with dilated cardiomyopathy.

Authors:  M Borggrefe; M Block; G Breithardt
Journal:  Br Heart J       Date:  1994-12

5.  [Risk stratification of sudden cardiac death in dilated cardiomyopathy. Programmed ventricular stimulation].

Authors:  Dietmar Bänsch
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2015-02-19

6.  Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy.

Authors:  Saman Nazarian; David A Bluemke; Albert C Lardo; Menekhem M Zviman; Stanley P Watkins; Timm L Dickfeld; Glenn R Meininger; Ariel Roguin; Hugh Calkins; Gordon F Tomaselli; Robert G Weiss; Ronald D Berger; João A C Lima; Henry R Halperin
Journal:  Circulation       Date:  2005-11-01       Impact factor: 29.690

7.  Programmed ventricular stimulation after myocardial infarction does not help reduce the risk of ventricular events.

Authors:  B Brembilla-Perrot; L Jacquemin; A Terrier de la Chaise; D Beurrier
Journal:  Cardiovasc Drugs Ther       Date:  1996-11       Impact factor: 3.727

Review 8.  [Limits and scopes of invasive risk stratification. Do we still need programmed ventricular stimulation?].

Authors:  Sascha Rolf; Wilhelm Haverkamp
Journal:  Herz       Date:  2009-11       Impact factor: 1.443

Review 9.  Stratification of the risk of sudden death in nonischemic heart failure.

Authors:  Maurício Pimentel; Leandro Ioschpe Zimerman; Luis Eduardo Rohde
Journal:  Arq Bras Cardiol       Date:  2014-08-29       Impact factor: 2.000

10.  Characteristics of syncope in patients with dilated cardiomyopathy.

Authors:  Abdel-Hadi Rami; Muresan Lucian; Pop Dana; Zdrenghea Dumitru
Journal:  Indian Heart J       Date:  2015-11-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.